Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir(R) platform.

January 12, 2026. Infinitusbio.AI, a U.S.-based Pharmatech company and creator of the proprietary Simulative AI Digital Cell Clone platform, and Oncovita, a Paris-based biotechnology company spun out ...
diginomica

Evergen and UiPath show how agentic AI tests process discipline in regulated industries

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Honeywell Launches Performance+ for Guided Work to Enable Faster, Smarter Supply Chain Operations

The technology transforms workforce data into real-time insights to maximize productivity, enhance decision-making and ...

Siemens Brings the Industrial Metaverse to Life With Digital Twin Composer

Siemens unveils industrial metaverse technology, delivering true industrial intelligence, by bringing together physical AI ...

Human In the Loop (HITL) - AI - What and WHY

As financial institutions accelerate their adoption of artificial intelligence, one principle is emerging as non‑negotiable: ...
TVBEurope

Case study: Delivering premium workflows to every project for Lost in Space

The Signiant Platform quickly enabled seamless collaboration across distributed teams for post production services company ...